Free Trial

BKV (NYSE:BKV) Reaches New 1-Year Low - Should You Sell?

BKV logo with Energy background
Remove Ads

BKV Corporation (NYSE:BKV - Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $15.00 and last traded at $17.19, with a volume of 691041 shares. The stock had previously closed at $15.90.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on BKV shares. KeyCorp dropped their price objective on BKV from $27.00 to $25.00 and set an "overweight" rating on the stock in a report on Tuesday, March 4th. Barclays upped their target price on shares of BKV from $24.00 to $30.00 and gave the company an "overweight" rating in a report on Thursday, January 30th. Truist Financial cut their price target on BKV from $31.00 to $30.00 and set a "buy" rating for the company in a research note on Monday, March 17th. Finally, Mizuho increased their price target on shares of BKV from $29.00 to $33.00 and gave the stock an "outperform" rating in a report on Monday, December 16th. Eight research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $28.00.

Get Our Latest Stock Analysis on BKV

BKV Price Performance

The business has a 50-day moving average price of $20.58 and a two-hundred day moving average price of $21.14.

BKV (NYSE:BKV - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.01 EPS for the quarter, beating analysts' consensus estimates of ($0.10) by $0.11. The company had revenue of $119.78 million for the quarter, compared to analyst estimates of $183.77 million. As a group, sell-side analysts forecast that BKV Corporation will post -1.82 EPS for the current year.

Remove Ads

Insider Activity at BKV

In other BKV news, insider Ethan Ngo sold 21,667 shares of the business's stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $20.09, for a total value of $435,290.03. Following the completion of the transaction, the insider now directly owns 286,008 shares in the company, valued at approximately $5,745,900.72. The trade was a 7.04 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO David Tameron sold 5,000 shares of BKV stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $20.03, for a total value of $100,150.00. Following the completion of the sale, the chief financial officer now directly owns 47,779 shares of the company's stock, valued at approximately $957,013.37. This represents a 9.47 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 41,667 shares of company stock valued at $851,490.

Institutional Trading of BKV

A number of hedge funds have recently added to or reduced their stakes in the business. Driehaus Capital Management LLC purchased a new position in BKV during the fourth quarter worth approximately $9,553,000. Geode Capital Management LLC acquired a new position in BKV in the fourth quarter valued at $7,728,000. Bank of New York Mellon Corp purchased a new stake in BKV during the fourth quarter valued at about $695,000. Corebridge Financial Inc. acquired a new stake in BKV during the fourth quarter worth about $170,000. Finally, SG Americas Securities LLC purchased a new position in shares of BKV in the 4th quarter worth about $157,000.

BKV Company Profile

(Get Free Report)

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.

Featured Stories

Should You Invest $1,000 in BKV Right Now?

Before you consider BKV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.

While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads